Neurogenetic variations in norepinephrine availability enhance perceptual vividness

Area of Science:

• Neuroscience
• Genetics
• Psychology

Background:

• Emotionally salient stimuli are perceived with greater vividness than neutral ones, a phenomenon known as emotionally enhanced vividness (EEV).
• Individual differences in EEV suggest underlying biological variations.
• The ADRA2b gene, coding for the α2b adrenoceptor, is implicated in norepinephrine pathways, which are crucial for emotional and perceptual processing.

Purpose of the Study:

• To investigate whether a deletion variant of the ADRA2b gene modulates BOLD activity related to EEV in humans.
• To explore the neurogenetic underpinnings of individual differences in perceptual vividness and emotional enhancement.

Main Methods:

• Functional magnetic resonance imaging (fMRI) was used to measure BOLD activity.
• Participants were genotyped for the ADRA2b deletion variant.
• Perceptual vividness and sensitivity to featural salience were assessed.

Main Results:

• ADRA2b deletion carriers exhibited higher perceptual vividness compared to noncarriers.
• The ventromedial prefrontal cortex (VMPFC) showed greater modulation by EEV in deletion carriers.
• Deletion carriers demonstrated increased sensitivity to featural salience, suggesting a broader role for norepinephrine in perception.
• Path analysis indicated distinct neural pathways for EEV in carriers (amygdala-lateral occipital complex plus VMPFC) versus noncarriers (amygdala-lateral occipital complex).

Conclusions:

• Common norepinephrine-related neurogenetic variations, specifically the ADRA2b deletion, enhance subjective perceptual vividness and its emotional enhancement.
• These findings highlight the role of neurogenetic factors in modulating the interplay between emotion, perception, and brain activity.